Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Degardin M, Oliveira J, Geoffrois L, Rolland F, Armand JP, Bastit P, Chauvergne J, Fargeot P, van Glabbeke M, Lentz MA, Tresca P, Boudillet J, Fumoleau P, Cappelaere P. Degardin M, et al. Among authors: armand jp. Ann Oncol. 1998 Oct;9(10):1103-7. doi: 10.1023/a:1008446706578. Ann Oncol. 1998. PMID: 9834823 Free article. Clinical Trial.
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, Kerbrat P, de Forni M, Lhommé C, Roche H, et al. Chauvergne J, et al. Among authors: armand jp. Eur J Cancer. 1993;29A(3):350-4. doi: 10.1016/0959-8049(93)90384-r. Eur J Cancer. 1993. PMID: 8398333 Clinical Trial.
Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck.
Cappelaere P, Guiochet N, Chauvergne J, Bastit P, Armand JP, Lentz MA, Van Glabbeke M, Herait P, Fumoleau P. Cappelaere P, et al. Among authors: armand jp. Eur J Cancer. 1992;28(2-3):484-5. doi: 10.1016/s0959-8049(05)80083-8. Eur J Cancer. 1992. PMID: 1591069 Clinical Trial. No abstract available.
An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R, Cappelaere P, Armand JP, Keiling R, Fargeot P, Bastit P, van Glabbeke M, Renard J, Earl H, Rubens R, et al. De Jager R, et al. Among authors: armand jp. Eur J Cancer Clin Oncol. 1984 Nov;20(11):1369-75. doi: 10.1016/0277-5379(84)90055-5. Eur J Cancer Clin Oncol. 1984. PMID: 6542006
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of Cancer.
Hurteloup P, Armand JP, Schneider M, Bastit P, Chevallier B, Pourny C, Keiling R, de Oliveira C, Hayat M, Thomas D, et al. Hurteloup P, et al. Among authors: armand jp. Eur J Cancer Clin Oncol. 1989 Mar;25(3):423-8. doi: 10.1016/0277-5379(89)90254-x. Eur J Cancer Clin Oncol. 1989. PMID: 2702996
Phase II clinical evaluation of doxifluridine.
Hurteloup P, Armand JP, Cappelaere P, Metz R, Kerbrat P, Keiling R, Fumoleau P, Fargeot P, Schraub S, Bastit P, et al. Hurteloup P, et al. Among authors: armand jp. Cancer Treat Rep. 1986 Jun;70(6):731-7. Cancer Treat Rep. 1986. PMID: 2942245
285 results